Overview

Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of REL-1017 (d-Methadone)

Status:
Completed
Trial end date:
2015-06-02
Target enrollment:
Participant gender:
Summary
This study evaluated the safety, tolerance, and pharmacokinetics (PK) of d-methadone in a limited dose range, in single administrations in humans.
Phase:
Phase 1
Details
Lead Sponsor:
Relmada Therapeutics, Inc.
Treatments:
D-methadone
Methadone